Literature DB >> 25538231

Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells.

Xinyu Wang1, Meng Li1, Zhiqiong Wang1, Sichong Han1, Xiaohu Tang1, Yunxia Ge1, Liqing Zhou2, Changchun Zhou3, Qipeng Yuan1, Ming Yang4.   

Abstract

MALAT1, a highly conserved long noncoding RNA, is deregulated in several types of cancers. However, its role in esophageal squamous cell carcinoma (ESCC) and its posttranscriptional regulation remain poorly understood. In this study we provide first evidences that a posttranscriptional regulation mechanism of MALAT1 by miR-101 and miR-217 exists in ESCC cells. This posttranscriptional silencing of MALAT1 could significantly suppress the proliferation of ESCC cells through the arrest of G2/M cell cycle, which may be due to MALAT1-mediated up-regulation of p21 and p27 expression and the inhibition of B-MYB expression. Moreover, we also found the abilities of migration and invasion of ESCC cells were inhibited after overexpression of miR-101, miR-217, or MALAT1 siRNA. This might be attributed to the deregulation of downstream genes of MALAT1, such as MIA2, HNF4G, ROBO1, CCT4, and CTHRC1. A significant negative correlation exists between miR-101 or miR-217 and MALAT1 in 42 pairs of ESCC tissue samples and adjacent normal tissues. Mice xenograft data also support the tumor suppressor role of both miRNAs in ESCCs.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cancer; Esophageal Squamous Cell Carcinoma; Gene Regulation; Long Noncoding RNA (Long ncRNA, LncRNA); MALAT1; MicroRNA (miRNA); Oncogene; miR-101; miR-217

Mesh:

Substances:

Year:  2014        PMID: 25538231      PMCID: PMC4326802          DOI: 10.1074/jbc.M114.596866

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  microRNAs: tiny regulators with great potential.

Authors:  V Ambros
Journal:  Cell       Date:  2001-12-28       Impact factor: 41.582

2.  3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA.

Authors:  Jeremy E Wilusz; Susan M Freier; David L Spector
Journal:  Cell       Date:  2008-11-28       Impact factor: 41.582

3.  A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas.

Authors:  R Lin; S Maeda; C Liu; M Karin; T S Edgington
Journal:  Oncogene       Date:  2006-07-31       Impact factor: 9.867

4.  The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth.

Authors:  Lars Henning Schmidt; Tilmann Spieker; Steffen Koschmieder; Sonja Schäffers; Julia Humberg; Dominik Jungen; Etmar Bulk; Antje Hascher; Danielle Wittmer; Alessandro Marra; Ludger Hillejan; Karsten Wiebe; Wolfgang E Berdel; Rainer Wiewrodt; Carsten Muller-Tidow
Journal:  J Thorac Oncol       Date:  2011-12       Impact factor: 15.609

5.  A functional BRCA1 coding sequence genetic variant contributes to risk of esophageal squamous cell carcinoma.

Authors:  Xiaojiao Zhang; Jinyu Wei; Liqing Zhou; Changchun Zhou; Juan Shi; Qipeng Yuan; Ming Yang; Dongxin Lin
Journal:  Carcinogenesis       Date:  2013-06-08       Impact factor: 4.944

6.  MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer.

Authors:  Ping Ji; Sven Diederichs; Wenbing Wang; Sebastian Böing; Ralf Metzger; Paul M Schneider; Nicola Tidow; Burkhard Brandt; Horst Buerger; Etmar Bulk; Michael Thomas; Wolfgang E Berdel; Hubert Serve; Carsten Müller-Tidow
Journal:  Oncogene       Date:  2003-09-11       Impact factor: 9.867

7.  Risk factors for oesophageal cancer in northeast China.

Authors:  J Hu; O Nyrén; A Wolk; R Bergström; J Yuen; H O Adami; L Guo; H Li; G Huang; X Xu
Journal:  Int J Cancer       Date:  1994-04-01       Impact factor: 7.396

8.  Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking.

Authors:  Y T Gao; J K McLaughlin; W J Blot; B T Ji; J Benichou; Q Dai; J F Fraumeni
Journal:  Int J Cancer       Date:  1994-07-15       Impact factor: 7.396

9.  Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.

Authors:  Sooryanarayana Varambally; Qi Cao; Ram-Shankar Mani; Sunita Shankar; Xiaosong Wang; Bushra Ateeq; Bharathi Laxman; Xuhong Cao; Xiaojun Jing; Kalpana Ramnarayanan; J Chad Brenner; Jindan Yu; Jung H Kim; Bo Han; Patrick Tan; Chandan Kumar-Sinha; Robert J Lonigro; Nallasivam Palanisamy; Christopher A Maher; Arul M Chinnaiyan
Journal:  Science       Date:  2008-11-13       Impact factor: 47.728

10.  A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains.

Authors:  John N Hutchinson; Alexander W Ensminger; Christine M Clemson; Christopher R Lynch; Jeanne B Lawrence; Andrew Chess
Journal:  BMC Genomics       Date:  2007-02-01       Impact factor: 3.969

View more
  125 in total

Review 1.  The role of microRNA in esophageal squamous cell carcinoma.

Authors:  Kazuto Harada; Yoshifumi Baba; Takatsugu Ishimoto; Hironobu Shigaki; Keisuke Kosumi; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  J Gastroenterol       Date:  2016-01-21       Impact factor: 7.527

2.  Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer via sponging miR-145.

Authors:  Hongzhi Lu; Yu He; Lin Lin; Zhengqin Qi; Li Ma; Li Li; Ying Su
Journal:  Tumour Biol       Date:  2015-08-27

3.  Silence of Long Noncoding RNA NEAT1 Inhibits Malignant Biological Behaviors and Chemotherapy Resistance in Gastric Cancer.

Authors:  Jiale Zhang; Bochao Zhao; Xiuxiu Chen; Zhenning Wang; Huimian Xu; Baojun Huang
Journal:  Pathol Oncol Res       Date:  2017-04-11       Impact factor: 3.201

Review 4.  Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma.

Authors:  John M Abraham; Stephen J Meltzer
Journal:  Gastroenterology       Date:  2017-05-18       Impact factor: 22.682

5.  MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p.

Authors:  Ke Liu; Jun Huang; Jiangdong Ni; Deye Song; Muliang Ding; Junjie Wang; Xianzhe Huang; Wenzhao Li
Journal:  Cell Cycle       Date:  2017-02-10       Impact factor: 4.534

6.  Comprehensive analysis of differentially expressed lncRNAs as diagnostic and prognostic markers for colorectal cancer.

Authors:  Xunlei Zhang; Xingsong Zhang; Lili Shen; Li Song; Jindong Wu; Guangxin Cao; Xin Chen; Bin Zhu
Journal:  Exp Ther Med       Date:  2019-09-30       Impact factor: 2.447

7.  Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression.

Authors:  Priyanka Kulkarni; Pritha Dasgupta; Nadeem S Bhat; Varahram Shahryari; Marisa Shiina; Yutaka Hashimoto; Shahana Majid; Guoren Deng; Sharanjot Saini; Z Laura Tabatabai; Soichiro Yamamura; Yuichiro Tanaka; Rajvir Dahiya
Journal:  Mol Cancer Res       Date:  2018-07-23       Impact factor: 5.852

8.  Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539.

Authors:  Rui Wang; Bin Zheng; Hongyan Liu; Xiuxian Wan
Journal:  Cell Cycle       Date:  2020-04-14       Impact factor: 4.534

Review 9.  Long noncoding RNAs are novel potential prognostic biomarkers for esophageal squamous cell carcinoma: an overview.

Authors:  Han-Yu Deng; Yun-Cang Wang; Peng-Zhi Ni; Yi-Dan Lin; Long-Qi Chen
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

10.  Prognostic value of long non-coding RNA MALAT1 in cancer patients.

Authors:  Yihua Wu; Wei Lu; Jinming Xu; Yu Shi; Honghe Zhang; Dajing Xia
Journal:  Tumour Biol       Date:  2015-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.